Abstract
Background: Diabetes is associated with a pro-inflammatory status characterized by an increased production of inflammatory molecules. Reactive Oxygen Species (ROS) and cAMP elevating agents represent two molecular systems, normally generated during inflammation. These molecules could be responsible for the alteration of signaling pathways. In the present paper we have studied the correlation between ROS generation and inositolpolyphosphates (InsP1, InsP2 InsP3 and InsP4) released by granulocytes from Type 1 diabetic patients (DM1) in the presence or in the absence of cyclic AMP-elevating agents. Methods: The effect of cAMP on ROS production was quantified in a chemoluminescence assay luminol-dependent (RLU/min). InsP1, InsP2 InsP3 and InsP4 were quantified by inositol-H3 in a Beta-counter and the results were expressed as count per minute (CPM). Results: The elevation of intracellular level of cAMP inhibited both InsP3 and ROS production in granulocytes from healthy subjects and activated in the cells from Type 1 diabetic patients. InsP1, InsP2 and InsP4 did not show significant alteration in both studied cells. There was a significant correlation between InsP3 and ROS in the presence of elevated content of cAMP. This correlation was observed in a 15 minutes reaction for healthy subjects and in 120 minutes for DM1. Conclusions: The importance of both InsP3 release and ROS production in an inflammatory process and tissue pathophysiology in Type 1 diabetic patients is still under debate because hyperglycemia accelerates generation of oxidative stress and may play an important role in the development of complications in diabetes. Thus, our results demonstrated alteration in metabolic response in granulocytes from Type 1 diabetic patients and it may be important for the development of therapeutic processes and drugs that interfere with signaling of ROS generation and may contribute to the improvement of the severe complications of diabetes.
Keywords: Type 1 diabetes, neutrophil, InsP3, ROS
Current Aging Science
Title: Correlation Between ROS Production and InsP3 Released by Granulocytes from Type 1 Diabetic Patients in a cAMP-Dependent Manner
Volume: 1 Issue: 1
Author(s): Miriam Martins Chaves, Daniela Caldeira Costa, Denniece Adriana da Costa Souza, Francisco das Chagas Lima e Silva and Jose Augusto Nogueira Machado
Affiliation:
Keywords: Type 1 diabetes, neutrophil, InsP3, ROS
Abstract: Background: Diabetes is associated with a pro-inflammatory status characterized by an increased production of inflammatory molecules. Reactive Oxygen Species (ROS) and cAMP elevating agents represent two molecular systems, normally generated during inflammation. These molecules could be responsible for the alteration of signaling pathways. In the present paper we have studied the correlation between ROS generation and inositolpolyphosphates (InsP1, InsP2 InsP3 and InsP4) released by granulocytes from Type 1 diabetic patients (DM1) in the presence or in the absence of cyclic AMP-elevating agents. Methods: The effect of cAMP on ROS production was quantified in a chemoluminescence assay luminol-dependent (RLU/min). InsP1, InsP2 InsP3 and InsP4 were quantified by inositol-H3 in a Beta-counter and the results were expressed as count per minute (CPM). Results: The elevation of intracellular level of cAMP inhibited both InsP3 and ROS production in granulocytes from healthy subjects and activated in the cells from Type 1 diabetic patients. InsP1, InsP2 and InsP4 did not show significant alteration in both studied cells. There was a significant correlation between InsP3 and ROS in the presence of elevated content of cAMP. This correlation was observed in a 15 minutes reaction for healthy subjects and in 120 minutes for DM1. Conclusions: The importance of both InsP3 release and ROS production in an inflammatory process and tissue pathophysiology in Type 1 diabetic patients is still under debate because hyperglycemia accelerates generation of oxidative stress and may play an important role in the development of complications in diabetes. Thus, our results demonstrated alteration in metabolic response in granulocytes from Type 1 diabetic patients and it may be important for the development of therapeutic processes and drugs that interfere with signaling of ROS generation and may contribute to the improvement of the severe complications of diabetes.
Export Options
About this article
Cite this article as:
Martins Chaves Miriam, Caldeira Costa Daniela, da Costa Souza Denniece Adriana, Chagas Lima e Silva Francisco das and Nogueira Machado Jose Augusto, Correlation Between ROS Production and InsP3 Released by Granulocytes from Type 1 Diabetic Patients in a cAMP-Dependent Manner, Current Aging Science 2008; 1 (1) . https://dx.doi.org/10.2174/1874609810801010051
DOI https://dx.doi.org/10.2174/1874609810801010051 |
Print ISSN 1874-6098 |
Publisher Name Bentham Science Publisher |
Online ISSN 1874-6128 |

- Author Guidelines
- Bentham Author Support Services (BASS)
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Role of Long Non-coding RNAs in the Pathogenesis of Alzheimer’s and
Parkinson’s Diseases
Current Aging Science Pleiotropic Effects of Glucagon-like Peptide-1 (GLP-1)-Based Therapies on Vascular Complications in Diabetes
Current Pharmaceutical Design Serotonin 1A Receptors on Astrocytes as a Potential Target for the Treatment of Parkinson’s Disease
Current Medicinal Chemistry The Effectiveness of Nurse- and Pharmacist-Directed Care in Diabetes Disease Management:A Narrative Review
Current Diabetes Reviews Nanoparticles: A Neurotoxicological Perspective
CNS & Neurological Disorders - Drug Targets Genetics of the First Seven Proprotein Convertase Enzymes in Health and Disease
Current Genomics Transthyretin Deposition in Familial Amyloidotic Polyneuropathy
Current Medicinal Chemistry Treatment Strategies Against Diabetic Foot Ulcer: Success so Far and the Road Ahead
Current Diabetes Reviews The Role of PGC-1α in the Pathogenesis of Neurodegenerative Disorders
Current Drug Targets Misoprostol Reverse Hippocampal Neuron Cyclooxygenase-2 Downstream Signaling Imbalance in Aluminum-Overload Rats
Current Alzheimer Research YKL-40 as a Potential Biomarker and a Possible Target in Therapeutic Strategies of Alzheimer’s Disease
Current Neuropharmacology GABAA Receptor Specific Pyrazolopyrimidines as Potential Imaging Agents: In Vivo Characteristics of a New 18F-labelled Indiplon Derivative
Current Radiopharmaceuticals On the Use of Hydrogels in Cell Encapsulation and Tissue Engineering Systems
Recent Patents on Drug Delivery & Formulation Modifier Gene Studies to Identify New Therapeutic Targets in Cystic Fibrosis
Current Pharmaceutical Design Synthesis of Benzophenonehydrazone Schiff Bases and their In Vitro Antiglycating Activities
Medicinal Chemistry Review of Recent Clinical Developments and Patents for the Treatment of Autoimmune and Inflammatory Diseases by Mesenchymal Stromal Cells
Recent Patents on Regenerative Medicine Interactions of VDAC with Proteins Involved in Neurodegenerative Aggregation: An Opportunity for Advancement on Therapeutic Molecules
Current Medicinal Chemistry Haptoglobin Polymorphism and Lacunar Stroke
Current Neurovascular Research Central Arterial Aging and Angiotensin II Signaling
Current Hypertension Reviews Glycogen Synthase Kinase-3: A Potential Target for Drug Discovery in the Treatment of Neurodegenerative Disorders
Current Enzyme Inhibition